The House Committee on Energy & Commerce Subcommittee on Health held a hearing Jan. 8 entitled “Legislative Proposals to Support Patient Access to Medicare Services.” Among the bills discussed was the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 (H.R. 5269).
The RESULTS Act would streamline the data collection process for private payer-based fee schedule payment rates with current, comprehensive commercial market data. Ultimately, it would help improve the long-term stability of Medicare beneficiary access to clinical diagnostic laboratory tests.
Susan Van Meter, president of the American Clinical Laboratory Association, testified in support of the RESULTS Act. In her witness testimony, Van Meter explained that the Clinical Laboratory Fee Schedule is fundamentally flawed and endorsed the RESULTS Act as a “commonsense, smart policy approach to reforming the Clinical Laboratory Fee Schedule and preventing deep Medicare cuts from taking effect Jan. 31.”
When questioned by Energy & Commerce Committee Chairman Brett Guthrie (R-Ky.) about how data collection affects rate setting and diagnostic innovation, Van Meter explained the RESULTS Act would provide the Centers for Medicare & Medicaid Services with up-to-date, representative commercial market data and help laboratories to invest in innovative diagnostic tools.
Bipartisan support for the bill was evident. Democratic full committee and subcommittee ranking members Reps. Frank Pallone (D-N.J.) and Diana DeGette (D-Colo.) acknowledged support from both major parties. Meanwhile, Rep. Gus Bilirakis (R-Fla.) submitted a letter of support for passage of the RESULTS Act from a consortium of patient and consumer groups.
If congressional action is not taken to pass to the RESULTS Act before Jan. 31, laboratories will see 15 percent cuts to nearly 800 tests.
Sources:
https://d1dth6e84htgma.cloudfront.net/01_08_2026_HE_Hearing_Memorandum_64161f7b03.pdf